The long-term avoided recurrences and recurrence-related cost of alectinib for postoperative adjuvant therapy in Chinese patients with early-stage ALK-positive non-small cell lung cancer
阿来替尼用于中国早期ALK阳性非小细胞肺癌患者术后辅助治疗的长期预防复发率及复发相关成本
期刊:Frontiers in Public Health
影响因子:3.4
doi:10.3389/fpubh.2025.1571980
Yan, Xuanxuan; Zhou, Sijuan; Hu, Jiahao; Xia, Yan; He, Haotian; Jovanoski, Nick; Arnold, Melina; Hu, Jian; Song, Pingping; Jiang, Benyuan; Zhang, Yong; Lu, Jingwen; Wu, Yilong; Ying, Xiaohua